retatrutide receptor targets Research Guide: What the Phase 2 Trial Data Reported (2026) The power of three: Retatrutide's

*Due to packaging redesign and improvements, these may not reflect exactly the product you receive* Write Your Own Review

However, the quality of these products may vary depending on the manufacturer

Ro publishes its own pricing separately, and a large platform's tiers can differ by product and program

Actual results may vary depending on benefit plan design, member demographics, programs implemented by the plan and other factors * 99.9% OF MEMBERS WILL NOT BE AFFECTED BY FORMULARY REMOVALS: CVS Health Trade Finance, Q2 2025

While many patients initially saw benefits, reports of serious gastrointestinal injuries, including gastroparesis, bowel obstruction, and gallbladder disease, have surfaced